The FY22 budget proposed by the White House doesn’t include sufficient funds to sustainably support NCI researchers, even though the proposal includes the largest ever funding increase for NIH, the American Association for Cancer Research said in a letter to House appropriators.
“I feel very strongly that we need to do better. We need to have a payline and success rate that is comparable to the other NIH institutes and centers. For example, the 12.8 percent success rate at the NCI is occurring while the NIH-wide success rate for RPGs is nearly 21 percent, allowing the other NIH institutes and centers to fund approximately one out of five promising proposals, as opposed to NCI’s ability to fund one out of eight promising proposals,” David Tuveson, AACR president, said to The Cancer Letter. “We need the NIH to be strong—we need the NCI to be at least as strong as the other institutes in the NIH, because if it’s not, it will drag cancer research down, and it will ultimately impact and derail the whole point of the NIH.”
